Aspire Biopharma completes $30 million acquisition of Dura Driver Control Systems

PUBT · 1d ago
Aspire Biopharma completes $30 million acquisition of Dura Driver Control Systems
  • Aspire Biopharma completed its acquisition of Dura Driver Control Systems, buying 100% of the shares for about USD 30 million cash.
  • Funding included a new USD 22.5 million senior secured revolving credit facility, supplemented by cash on hand.
  • Dura Driver Control Systems reported USD 209.5 million revenue, USD 22.3 million adjusted EBITDA for 2025.
  • For the six months ended June 30, 2026, DCS generated about USD 103.9 million revenue, USD 10.5 million adjusted EBITDA.
  • DCS CEO Hans Vorstenbosch remains in charge of the unit, with the existing management team.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608100830ACCESSWRNAPR_____1205431) on August 10, 2026, and is solely responsible for the information contained therein.